STAFF PROFILE
Katie Flanagan
Position:
Honorary Professor
College / Portfolio:
STEM College
Email:
katie.flanagan@rmit.edu.au
Campus:
City Campus
Contact me about:
Research supervision
- Kampan, N.,Kartikasari, A.,Deceneux, C.,Flanagan, K.,Plebanski, M., et al, . (2023). Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses In: Cancers, 15, 1 - 20
- Gulliver, E.,Adams, V.,Marcelino, V.,Boer, J.,Flanagan, K.,Plebanski, M.,Moore, R., et al, . (2023). Extensive genome analysis identifies novel plasmid families in Clostridium perfringens In: Microbial genomics, 9, 1 - 16
- McLeod, C.,Ramsay, J.,Flanagan, K.,Plebanski, M., et al, . (2023). Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO) In: Trials, 24, 1 - 14
- Benn, C.,Amenyogbe, N.,Bjorkman, A.,Flanagan, K.,Aaby, P., et al, . (2023). Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines In: Drug Safety, 46, 439 - 448
- Herd, S.,Allen, P.,Reed, L.,O'Hern, J.,Fraser, J.,Flanagan, K. (2023). In press - Time to embrace sepsis pathways and antibiotic prescribing decision support in the emergency department: Observations from a retrospective single site clinical audit In: EMA - Emergency Medicine Australasia, , 1 - 8
- Asrani, P.,Tiwari, K.,Eapen, M.,Flanagan, K., et al, . (2022). Clinical features and mechanistic insights into drug repurposing for combating COVID-19 In: International Journal of Biochemistry and Cell Biology, 142, 1 - 12
- Tan, H.,Wragg, K.,Kelly, H.,Flanagan, K. L., et al, . (2022). Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil In: Journal of immunology, 208, 2267 - 2271
- Rowntree, L.,Nguyen, T.,Kedzierski, L.,Flanagan, K. L., et al, . (2022). SARS-CoV-2-specific T cell memory with common TCR?? motifs is established in unvaccinated children who seroconvert after infection In: Immunity, 55, 1299 - 1315
- Moody, R.,Smith, K.,Flanagan, K.,Plebanski, M., et al, . (2022). Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better clinical outcomes In: Frontiers in Immunology, 13, 1 - 16
- Hensen, L.,Illing, P.,Rowntree, L.,Flanagan, K., et al, K. (2022). T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles In: Frontiers in Immunology, 13, 1 - 23